AIM ImmunoTech (AIM) Shares Issued (2018 - 2025)
Historic Shares Issued for ImmunoTech (AIM) over the last 10 years, with Q3 2025 value amounting to $6.5 million.
- ImmunoTech's Shares Issued rose 41976.19% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 21391.59%. This contributed to the annual value of $649916.0 for FY2024, which is 3400.33% up from last year.
- Per ImmunoTech's latest filing, its Shares Issued stood at $6.5 million for Q3 2025, which was up 41976.19% from $105000.0 recorded in Q2 2025.
- ImmunoTech's Shares Issued's 5-year high stood at $6.5 million during Q3 2025, with a 5-year trough of -$210084.0 in Q4 2024.
- In the last 3 years, ImmunoTech's Shares Issued had a median value of $233000.0 in 2023 and averaged $882265.1.
- The largest annual percentage gain for ImmunoTech's Shares Issued in the last 5 years was 1044000.0% (2024), contrasted with its biggest fall of 24291.43% (2024).
- Quarter analysis of 3 years shows ImmunoTech's Shares Issued stood at $147000.0 in 2023, then crashed by 242.91% to -$210084.0 in 2024, then soared by 3217.32% to $6.5 million in 2025.
- Its Shares Issued stands at $6.5 million for Q3 2025, versus $105000.0 for Q2 2025 and $660000.0 for Q1 2025.